Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer vaccine
Pharma
JPM24: Merck expects $20B in new cancer sales from pipeline meds
The improved outlook now includes three antibody-drug conjugates that Merck got from Daiichi Sankyo and the Moderna-partnered mRNA cancer vaccine.
Angus Liu
Jan 9, 2024 6:20am
Moderna, BioNTech's post-COVID futures hit manufacturing reality
Oct 24, 2023 8:31am
PsiOxus is no more: Meet Akamis Bio
Jan 6, 2023 9:00am
GSK, Sanofi vaccines safe from an mRNA downfall, analysts argue
Jun 16, 2021 11:15am
Takeda, Merck-Eisai, Daewoong-Evolus—Fierce Pharma Asia
Feb 19, 2021 10:25am
Merck cashes in on Moderna COVID-19 vaccine enthusiasm
Dec 2, 2020 11:48am
